Drug-eluting stents versus bilateral internal thoracic grafting for multivessel coronary disease

Itzhak Herz1, Yaron Moshkovitz, Dan Loberman

  • 1Department of Cardiology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Insights

Bilateral internal thoracic artery (BITA) grafting shows better midterm outcomes than drug-eluting stent (Cypher) percutaneous coronary intervention (PCI) for multivessel revascularization, with lower rates of angina recurrence and reintervention.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Medical Technology

Background:

  • Drug-eluting stents, such as Cypher, have shown reduced restenosis and reinterventions.
  • This study directly compares multivessel Cypher stenting with bilateral internal thoracic artery (BITA) grafting.

Purpose of the Study:

  • To compare the midterm clinical outcomes of multivessel myocardial revascularization using Cypher drug-eluting stents versus BITA grafting.
  • To evaluate rates of restenosis, reintervention, and angina recurrence between the two revascularization methods.

Main Methods:

  • A comparative study of 226 patients (113 per group) undergoing multivessel myocardial revascularization from January 2002 to June 2004.
  • Patients were matched for age, sex, ejection fraction, extent of coronary disease, and congestive heart failure.
  • Outcomes including mortality, angina recurrence, and reintervention rates were analyzed over a 6 to 34-month follow-up period.

Main Results:

  • BITA grafting treated more coronary vessels per patient (2.87 vs 2.22).
  • The Cypher group had significantly higher rates of angina recurrence (28.3% vs 12.4%) and reinterventions (14.2% vs 5.3%).
  • One-year reintervention-free survival was superior for BITA grafting (96%) compared to Cypher stenting (86.6%).

Conclusions:

  • Despite advancements in percutaneous coronary intervention (PCI) with drug-eluting stents, BITA grafting offers superior midterm clinical outcomes for multivessel revascularization.
  • BITA grafting is associated with a lower incidence of angina recurrence and need for reintervention compared to Cypher stenting.
Abstract

Related Concept Videos